ReproCELL Incorporated
4978.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥13,649,303 | ¥13,499,959 | ¥20,299,430 | ¥17,240,423 |
| - Cash | ¥2,823,367 | ¥2,939,057 | ¥1,914,569 | ¥2,641,976 |
| + Debt | ¥0 | ¥0 | ¥0 | ¥80,000 |
| Enterprise Value | ¥10,825,936 | ¥10,560,902 | ¥18,384,861 | ¥14,678,447 |
| Revenue | ¥2,978,627 | ¥2,426,817 | ¥2,953,271 | ¥2,234,568 |
| % Growth | 22.7% | -17.8% | 32.2% | – |
| Gross Profit | ¥1,646,373 | ¥1,120,817 | ¥1,141,247 | ¥803,439 |
| % Margin | 55.3% | 46.2% | 38.6% | 36% |
| EBITDA | ¥95,759 | ¥8,245 | -¥254,587 | -¥513,849 |
| % Margin | 3.2% | 0.3% | -8.6% | -23% |
| Net Income | ¥103,245 | -¥31,415 | -¥305,313 | -¥575,094 |
| % Margin | 3.5% | -1.3% | -10.3% | -25.7% |
| EPS Diluted | 1.11 | -0.37 | -3.62 | -7.57 |
| % Growth | 400% | 89.8% | 52.2% | – |
| Operating Cash Flow | ¥6,287 | -¥11,451 | -¥140,534 | -¥246,244 |
| Capital Expenditures | -¥86,689 | -¥192,433 | -¥161,032 | -¥48,030 |
| Free Cash Flow | -¥80,402 | -¥203,884 | -¥301,566 | -¥294,274 |